» Articles » PMID: 1979834

Graded Cytopathogenicity of the Human Immunodeficiency Virus (HIV) in the Course of HIV Infection

Overview
Date 1990 Jan 1
PMID 1979834
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

To determine whether the biological variability of HIV-1 has any clinical significance, the highly variable cytopathogenicity of 153 HIV-1 strains, isolated from 119 hemophiliacs, was related to the number of CD4+ lymphocytes present in the patient's blood at the time of virus isolation. It was shown that the cytopathogenicity of the HIV-1 isolates was inversely correlated with the number of CD4+ lymphocytes. The highest CD4+ cell number were observed in 34 latently infected patients characterized by HIV seropositivity, failure of virus isolation, and detection of viral DNA by the polymerase chain reaction. Cytopathogenicity of the HIV-1 isolates was a reliable prognostic marker and correlated well with other less-sensitive prognostic parameters, including the detection of infectious virus and p24 antigen in the plasma, and the decline of p24 antibody in the serum. The results suggest that the viral isolates - if not subjected to extensive passage - represent in vivo variants selected from a heterogeneous viral population according to the particular immunological conditions of the host.

Citing Articles

An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.

Bozek K, Eckhardt M, Sierra S, Anders M, Kaiser R, Krausslich H Retrovirology. 2012; 9:60.

PMID: 22830600 PMC: 3464718. DOI: 10.1186/1742-4690-9-60.


Guarding against the most dangerous emerging pathogens.

Ewald P Emerg Infect Dis. 1996; 2(4):245-57.

PMID: 8969242 PMC: 2639916. DOI: 10.3201/eid0204.960401.


HIV colonizing peripheral blood monocytes follows lymphocytic isolates in shifting from NSI to SI genotype.

Witt A, Kaiser R, Mayer A, Rolf R, Matz B, SCHNEWEIS K Arch Virol. 1996; 141(10):1833-46.

PMID: 8920819 DOI: 10.1007/BF01718198.


Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication.

Kleim J, Bender R, Kirsch R, Meichsner C, Paessens A, Rosner M Antimicrob Agents Chemother. 1995; 39(10):2253-7.

PMID: 8619578 PMC: 162925. DOI: 10.1128/AAC.39.10.2253.


Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.

Zhang L, Mackenzie P, Cleland A, Holmes E, Brown A, Simmonds P J Virol. 1993; 67(6):3345-56.

PMID: 8497055 PMC: 237678. DOI: 10.1128/JVI.67.6.3345-3356.1993.


References
1.
Anand R, Siegal F, Reed C, Cheung T, Forlenza S, Moore J . Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders. Lancet. 1987; 2(8553):234-8. DOI: 10.1016/s0140-6736(87)90826-9. View

2.
Kamradt T, Niese D, SCHNEWEIS K, Brackmann H, Kamps B, van Loo B . Natural history of HIV-infection in hemophiliacs: clinical, immunological, and virological findings. Klin Wochenschr. 1989; 67(20):1033-41. DOI: 10.1007/BF01727005. View

3.
Evans L, McHugh T, Stites D, Levy J . Differential ability of human immunodeficiency virus isolates to productively infect human cells. J Immunol. 1987; 138(10):3415-8. View

4.
Goodenow M, Huet T, Saurin W, Kwok S, Sninsky J, Wain-Hobson S . HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr (1988). 1989; 2(4):344-52. View

5.
Weiss R, Clapham P, Weber J, Dalgleish A, Lasky L, BERMAN P . Variable and conserved neutralization antigens of human immunodeficiency virus. Nature. 1986; 324(6097):572-5. DOI: 10.1038/324572a0. View